Mad Consultant Ltd Secures £10k Capital Injection

Mad Consultant Ltd, a UK-based firm specialising in information technology consultancy activities, has recently secured a capital injection amounting to £10,000. The filing for this funding round was made on 10 April 2026, with the allotment date recorded as 1 February 2026. This early-stage capital represents a modest boost for the Worcester Park-headquartered company.

Incorporated on 19 April 2018, Mad Consultant Ltd operates within the information technology consultancy sector, providing specialised services. While specific details regarding the problems the company aims to solve for its clients were not disclosed, its sector classification indicates a focus on offering expert advice and solutions in the IT domain. According to its latest available accounts, the company currently employs two individuals. Further financial metrics such as revenue, profit, or loss figures were not made public at the time of this report.

The recent funding round saw Mad Consultant Ltd raise an estimated £10,000. Details regarding the company's valuation post-investment were not disclosed, nor were the names of the investors participating in this round. Information regarding any previous funding rounds for Mad Consultant Ltd was also not available, making a direct comparison to past capital raises unfeasible.

In the broader context of the UK funding landscape, a £10,000 capital injection is considered a very early-stage or pre-seed amount, often indicative of initial founder investment, small angel contributions, or early operational capital. While the UK's information technology consultancy sector frequently attracts significant venture capital, particularly for scalable software-as-a-service (SaaS) or deep tech solutions, this particular raise for Mad Consultant Ltd is at the smaller end of the spectrum. It suggests a focus on foundational development or very early operational expenses rather than substantial growth capital typically associated with larger VC rounds. The absence of named investors or a disclosed valuation further points to the nascent stage of this funding event within the company's lifecycle.